Bernhard J. Eigl

机构：BC Cancer Agency, University of British Columbia, Vancouver Prostate Centre · ORCID：0000-0003-1653-6929

发表论文 345 篇 · 总被引 10657 次 · h-index 37

代表论文

Circulating tumor DNA (ctDNA) in patients with muscle-invasive bladder cancer (MIBC) who received perioperative durvalumab (D) in NIAGARA. (2025 · Journal of Clinical Oncology · 被引 45)
A first-in-human phase 1 study of LY3866288 (LOXO-435), a potent, highly isoform-selective FGFR3 inhibitor (FGFR3i) in advanced solid tumors with FGFR3 alterations: Initial results from FORAGER-1. (2025 · Journal of Clinical Oncology · 被引 15)
Urinary tumor DNA (utDNA) and circulating tumor DNA (ctDNA) in patients (pts) with muscle-invasive bladder cancer (MIBC) who received perioperative durvalumab (D) in NIAGARA. (2026 · Journal of Clinical Oncology · 被引 7)
ERBB2 /HER2 Alterations in ctDNA and Metachronous Tissues of Patients with Metastatic Urothelial Cancer (2025 · Clinical Cancer Research · 被引 5)
NEO-BLAST: Neoadjuvant therapy for bladder cancer followed by active surveillance vs treatment. (2025 · Journal of Clinical Oncology · 被引 5)
Clonal hematopoiesis in metastatic urothelial and renal cell carcinoma (2025 · npj Precision Oncology · 被引 4)